ArticleArXiv2025
An affordable, wearable, fiber-free pulsed-mode diffuse speckle contrast flowmetry (PM-DSCF) sensor for noninvasive measurements of deep cerebral blood flow.
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Significance: Measuring cerebral blood flow (CBF) is crucial for diagnosing various cerebral diseases. An affordable, wearable, and fiber-free continuous-wave speckle contrast flowmetry (CW-DSCF) technique has been developed for continuous monitoring of CBF variations. However, its application in adult humans is limited by shallow tissue penetration. Aim: To develop an innovative pulse-mode DSCF (PM-DSCF) system for continuous monitoring of CBF variations in adult humans. Approach: The PM-DSCF utilizes an 808 nm laser diode and a small NanEye camera to capture diffuse laser speckle fluctuations caused by red blood cell movement in the brain (i.e., CBF). Operating in short-pulse mode (duty cycle < 5%), the system maximizes peak pulse light power for deeper tissue penetration, while ensuring that the average power density remains within ANSI safety standards for skin exposure. The PM-DSCF was evaluated on tissue-simulating phantoms and in adult humans. Results: The maximum effective source-detector distance increased from 15 mm (CW-DSCF) to 35 mm (PM-DSCF). The PM-DSCF successfully detected CBF variations in adult brains during head-up-tilting experiments, consistent with physiological expectations. Conclusions: Switching from CW mode to PM mode significantly increases the maximum tissue penetration depth from ~7.5 mm (CW-DSCF) to ~17.5 mm (PM-DSCF), enabling successful CBF measurements in adult humans.
Indexed as
Identifiers
39990801PMC11844631What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.